Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.

Balwit JM, Hwu P, Urba WJ, Marincola FM.

J Transl Med. 2011 Jan 31;9:18. doi: 10.1186/1479-5876-9-18. Review.

2.

Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.

Balwit JM, Kalinski P, Sondak VK, Coulie PG, Jaffee EM, Gajewski TF, Marincola FM.

J Transl Med. 2011 May 12;9:60. doi: 10.1186/1479-5876-9-60.

3.

Summary of the primer on tumor immunology and the biological therapy of cancer.

Li Y, Liu S, Margolin K, Hwu P.

J Transl Med. 2009 Jan 28;7:11. doi: 10.1186/1479-5876-7-11.

4.

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.

Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM.

J Transl Med. 2010 Dec 7;8:130. doi: 10.1186/1479-5876-8-130.

5.

Pioneering the trail of cancer immunotherapy.

Kotlan B, Balwit JM.

Expert Rev Anticancer Ther. 2011 Mar;11(3):351-4. doi: 10.1586/era.10.229.

PMID:
21417850
6.
7.

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Håkansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL Jr, Song W, Stroncek DF, Tahara H, Thurin M, Trinchieri G, van Der Burg SH, Whiteside TL, Wigginton JM, Marincola F, Khleif S, Fox BA, Disis ML.

Clin Cancer Res. 2011 May 15;17(10):3064-76. doi: 10.1158/1078-0432.CCR-10-2234. Epub 2011 May 10. Review.

8.

Conference scene: Immune signatures in the tumor and beyond.

Kandalaft LE, Kalos M, Melief CJ, Speiser DE, Coukos G.

Immunotherapy. 2012 Aug;4(8):761-72. doi: 10.2217/imt.12.70.

9.

SITC 26th annual meeting--summary.

Romano E, Nardelli-Haefliger D, Donda A, Corgnac S, Romero P.

J Transl Med. 2012 May 23;10:105. doi: 10.1186/1479-5876-10-105.

10.

Toward integrative cancer immunotherapy: targeting the tumor microenvironment.

Emens LA, Silverstein SC, Khleif S, Marincola FM, Galon J.

J Transl Med. 2012 Apr 10;10:70. doi: 10.1186/1479-5876-10-70.

11.

The immune score as a new possible approach for the classification of cancer.

Galon J, Pagès F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA.

J Transl Med. 2012 Jan 3;10:1. doi: 10.1186/1479-5876-10-1.

12.
13.

Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE, Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG.

J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.

PMID:
22147736
14.
15.

JTM's Tumor immunology goes broad: announcing the Immunobiology and Immunotherapy section.

Bot A, Marincola F, Romero P.

J Transl Med. 2013 Jan 4;11:2. doi: 10.1186/1479-5876-11-2.

16.

Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.

Gulley JL, Repasky EA, Wood LS, Butterfield LH.

J Immunother Cancer. 2017 Jul 18;5(1):55. doi: 10.1186/s40425-017-0262-1. Review.

17.

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer.

Raval RR, Sharabi AB, Walker AJ, Drake CG, Sharma P.

J Immunother Cancer. 2014 May 14;2:14. doi: 10.1186/2051-1426-2-14. eCollection 2014. Review.

18.

Dendritic cells in tumor immunology and immunotherapy.

Turtle CJ, Hart DN.

Curr Drug Targets. 2004 Jan;5(1):17-39. Review.

PMID:
14738216
19.

Oncology meets immunology: the cancer-immunity cycle.

Chen DS, Mellman I.

Immunity. 2013 Jul 25;39(1):1-10. doi: 10.1016/j.immuni.2013.07.012. Review.

20.

Announcing the tumor immunology and biological cancer therapy section (edited by iSBTc) of the Journal of Translational Medicine.

Romero P, Fox BA; iSBTc Executive Office.

J Transl Med. 2009 Sep 17;7:80. doi: 10.1186/1479-5876-7-80. No abstract available.

Supplemental Content

Support Center